Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 3 Impact of randomization to stenting versus balloon angioplasty (pooled regardless of abciximab administration), and to abciximab versus no abciximab (pooled regardless of stent use) on one-year mortality as a function of the severity of baseline mitral regurgitation. Solid bars = percutaneous transluminal coronary angioplasty; open bars = stent; striped bars = no abciximab; checkered bars = abciximab.
|
